I think CTIX hands the keys to the Ferrari and lets Pfizer
I think CTIX hands the keys to the Ferrari and lets Pfizer take complete control of K and decide how they want to commercialize/ license it. For us as investors, we will all get our big payday at that point, and Dr Menon and Leo get their ultimate goal of bringing the biggest cancer drug in history to market.
We investors always think in terms of portfolio gains and dollar signs, but these gentlemen transcend beyond simple financial concerns as they are both already well off. This is about making history, leaving a legacy, and cementing the elite status of themselves and many of their associates at the premiere cancer institutions in the world. Our scientific advisory panel is a dream team of oncology researchers because they all see the magnitude of whats about to happen here, and they want to be a part of history as well.
And of course, at the point Dr Menon will basically have unlimited funding to run KARD, and continue to follow his passion of bringing new cures to an ailing population. He and Leo will both have more than enough money to ride off into the sunset if they wish, a fitting conclusion to an epic journey that will save the lives of millions.
Truly, the nobel prize should not be out of the question here given the profound impact K will have all over the world.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...
Continue Reading
Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...
Continue Reading
illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...
Continue Reading
You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....
Continue Reading
Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...
Continue Reading
Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...
Continue Reading
An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...
Continue Reading
Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...
Continue Reading
A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...
Continue Reading
Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...
Continue Reading
Top 5 Most Recently Viewed Articles
Canaccord Genuity Raises Price Target for Roblox Recently, Canaccord Genuity, a leading financial services firm, announced an adjustment to its price target for Roblox Corp. (NYSE: RBLX). The firm raised the target to $60, a notable increase from the prior target of $50. This update accompanies a maintained Buy rating, reflecting confidence in Roblox's performance...
Continue Reading
Protara Therapeutics Announces Inducement Stock Awards Protara Therapeutics, Inc. (Nasdaq: TARA) is thrilled to share the exciting news about the granting of inducement non-qualified stock options and restricted stock units (RSUs) to two newly-hired employees. This pivotal moment reflects Protara’s commitment to attracting top talent as it continues its mission to...
Continue Reading
Yunnan's Cultural Showcase at Greater Bay Area Conference During the recent Greater Bay Area Conference 2025, Yunnan's unique offerings captivated attendees, highlighting the province's rich culture and cuisine. The event, focused on financial connectivity and cultural exchanges, saw Yunnan's Provincial Department of Culture and Tourism present a range of local...
Continue Reading
Albion VCTs Announce Upcoming Share Subscription Offers Albion Crown VCT PLC, Albion Enterprise VCT PLC, and Albion Technology & General VCT PLC, collectively known as Albion VCTs, are on the verge of launching a significant share subscription opportunity. This initiative aims to invite investors to participate in the proposed issuance of new ordinary shares for the...
Continue Reading
OSB Group PLC Shareholder Notification LEI: 213800ZBKL9BHSL2K459 In a recent development within OSB Group PLC, the company announced that Jason Elphick, serving as the Group General Counsel and Company Secretary, sold 9,301 ordinary shares at a price of £4.571014 each. This transaction, conducted via a nominee account, highlights significant activities among persons...
Continue Reading